Navigation Links
Ghrelin increases willingness to pay for food
Date:7/11/2011

07/07/11, Clearwater Beach, FL. Research to be presented at the upcoming annual meeting of the Society for the Study of Ingestive Behavior (SSIB), the foremost society for research into all aspects of eating and drinking behavior, suggests that ghrelin, a naturally occurring gut hormone, increases our willingness to pay for food, while simultaneously decreasing our willingness to pay for non-food items.

Have you ever wondered about why you are willing to pay more for food when you are hungry? Ghrelin, a naturally occurring gut hormone that signals hunger by acting on the brain, is instrumental in this process. One way that ghrelin acts is by increasing activity in brain "reward" regions when people view pictures of food. In this new study, the authors were interested in whether ghrelin affects people's willingness to pay for food and non-food items. Brain activity was examined using functional MRI in normal weight volunteers while they placed bids for food or for non-food trinkets after being injected with ghrelin, or after being injected only with saline.

Ghrelin treatment significantly increased the willingness of study subjects to pay for food items, but reduced their willingness to pay for non-food trinkets. As expected, activity within several brain reward regions was correlated with bid values on both food and non-food items when subjects were treated with saline. However, when subjects were treated with ghrelin, such correlated activity was limited to a unique brain reward region, the nucleus accumbens.

These results support the view that ghrelin increases hunger and eating, in part, by increasing reward signaling specifically in the nucleus accumbens. A better grasp of brain reward signaling mechanisms may lead to better ways to control appetite and fight obesity.


'/>"/>

Contact: Jamie Price
jamie@spltrak.com
312-238-9068
Society for the Study of Ingestive Behavior
Source:Eurekalert

Page: 1

Related biology news :

1. Hormone ghrelin can boost resistance to Parkinsons disease
2. Exercise increases brain growth factor and receptors, prevents stem cell drop in middle age
3. European ancestry increases breast cancer risk among Latinas
4. Long-term use of diabetes drugs by women significantly increases risk of fractures
5. Sweetened beverage consumption increases in the US
6. Gene mutation increases drug toxicity, rejection risk in pediatric kidney transplants
7. Indoor air pollution increases asthma symptoms
8. Lower increases in global temps could lead to greater impacts than previously thought, study finds
9. Agent Orange exposure increases veterans risk of aggressive recurrence of prostate cancer
10. Researchers identify a molecule that increases the risk of cardiac insufficiency
11. The battle for CRTC2: How obesity increases the risk for diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/6/2017)... Jan. 5, 2017  SomaLogic announced today that ... Alliance" established by iCarbonX, the China ... a "Global Digital Health Ecosystem that can define ... of individual,s biological, behavioral and psychological data, the ... the companies, SomaLogic will provide proteomics data and ...
(Date:1/4/2017)...  For the thousands of attendees at this year,s International Consumer Electronics ... and biometric measurement devices and services, will be featuring its new line ... A&D Medical,s special CES Exhibit Suite , the new upper arm ... company,s WellnessConnected product platform.  ... ...
(Date:1/3/2017)... 2017 Onitor, provider of digital health technology ... an innovative biometric data-driven program designed to aid weight ... the 2017 Consumer Electronics Show (CES) in ... U.S., the World Health Organization (WHO), have identified lifestyle ... who are overweight or obese. WHO also states that ...
Breaking Biology News(10 mins):
(Date:1/18/2017)... --  Boston Biomedical , an industry leader in the ... pathways, will feature data from two clinical studies for ... Gastrointestinal Cancers Symposium, held from January 19-21, in ... is an orally-administered investigational agent designed to inhibit cancer ... cells (CSCs) possess the property of stemness – the ...
(Date:1/18/2017)... ... January 18, 2017 , ... ... Ops Executives 2017 in its continued commitment to the advancement of the clinical ... discuss current issues related to clinical trial planning and management. , As ...
(Date:1/18/2017)... , ... January 18, 2017 , ... ... federally funded bio-focused Manufacturing Innovation Institutes (MII). U.S. Secretary of Commerce Penny Pritzker ... Biopharmaceuticals (NIIMBL), and the Department of Defense has announced the award of a ...
(Date:1/18/2017)... PRUSSIA, PA (PRWEB) , ... January 18, 2017 ... ... clinical operations again at the CHI SCOPE Summit for Clinical Ops Executives (Hyatt ... in engaging panel discussions to examine vital clinical research issues such as trial ...
Breaking Biology Technology: